Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 7—July 2003
Dispatch

Leishmaniasis in Germany

Gundel Harms*Comments to Author , Gabriele Schönian*, and Hermann Feldmeier†
Author affiliations: *Charité, Humboldt University Berlin, Berlin, Germany; †Free University of Berlin, Berlin, Germany

Main Article

Table 1

Characteristics of patients with cutaneous and mucosal leishmaniasis, Germanya

No. Exposure Status Sex Age (y) Leishmania species Treatment Outcome
Europe

1
France
Tourist
F
64
L. donovani complex
No treatment
No cure
2
Italy
Tourist
F
24
L. donovani complex
Liposomal amphotericin B
Improved
3
Malta
Tourist
M
22
L. donovani complex
Perilesional pentavalent antimonials
Cured
4
Malta
Tourist
M
39
L. donovani complex
Perilesional pentavalent antimonials
Cured
5
Malta
Tourist
F
57
n.d.
Perilesional pentavalent antimonials
Cured
6
Malta
Tourist
M
62
n.d.
Perilesional pentavalent antimonials
Cured
7
Spain (Majorca)
Tourist
F
5
n.d.
Pentamidine isethionate
Cured
8
Spain (Majorca)
Tourist
M
13
L. donovani complex
Perilesional pentavalent antimonials
Cured
9
Spain
Tourist
F
31
L. donovani complex
No treatment
Unknown
10
Spain
Tourist
M
33
L. donovani complex
Antibiotic
Cured
Americas

11
Belize
Tourist
M
36
L. braziliensis complex
Liposomal amphotericin B
Unknown
12
Belize
Tourist
F
32
n.d.
IFN-gamma
Cured
13
Bolivia
Tourist
M
35
L. braziliensis complex
Liposomal amphotericin B
Unknown
14
Brazil
Tourist
M
25
n.d.
Systemic pentavalent antimonials
Cured
15
Brazil
Tourist
M
39
L. braziliensis complex
Liposomal amphotericin B
Unknown
16
Brazil
Tourist
M
33
L. braziliensis complex
Liposomal amphotericin B
Cured
17
Ecuador
Tourist
F
29
L. braziliensis complex
Liposomal amphotericin B
Cured
18
Ecuador
Tourist
M
36
n.d.
Liposomal amphotericin B
Cured
19
French Guyana
Work stay
M
28
L. braziliensis complex
Liposomal amphotericin B
Cured
20
French Guyana
Work stay
M
22
L. braziliensis complex
Liposomal amphotericin B
Cured
21
Guatemala
Tourist
M
31
L. mexicana
Ketokonazole
Cured
22
Peru
Work stay
F
25
L. braziliensis complex
Liposomal amphotericin B
Cured
23
Peru
Tourist
F
33
L. braziliensis complex
Liposomal amphotericin B
Cured
24
Peru
Tourist
M
35
L. braziliensis complex
Liposomal amphotericin B
Cured
Asia

25
Afghanistan
Immigrant
M
21
L. tropica
Aminosidine ointment
No cure
26
Afghanistan
Tourist
F
12
n.d.
Aminosidine ointment
Cured
27
United Arab Emirates
Tourist
F
44
n.d.
Perilesional pentavalent antimonials
Cured
28
Syria
Tourist
M
5
n.d.
Perilesional pentavalent antimonials
Unknown
29
Syria
Tourist
F
3
n.d.
Perilesional pentavalent antimonials
Unknown
30
Turkey
Tourist
F
33
n.d.
Antibiotic
Cured
31
Turkey
Tourist
M
37
L. donovani complex
Liposomal amphotericin B
Improved
Africa

32
Egypt
Tourist
M
25
L. tropica
Aminosidine ointment
No cure
33
Egypt
Tourist
F
27
L. tropica
Aminosidine ointment
Cured
34
Kenya
Tourist
M
50
n.d.
Perilesional pentavalent antimonials
Cured
35 Lybia Work stay M 34 n.d. Aminosidine ointment Cured

an.d., not done; IFN, interferon.

Main Article

Page created: December 22, 2010
Page updated: December 22, 2010
Page reviewed: December 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external